(Q31162542)

29 June 2017

Comparison of nebuliser efficiency for aerosolizing pentamidine (English)

1 reference

nebulizers and vaporizers

29 June 2017

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

author name string

D. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

D. Erskine

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

J. Steele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

D. Hills

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

B. Gazzard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350636

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1350636

17 September 2022

publication date

1 January 1992

1 reference

Journal of Pharmacy and Pharmacology

29 June 2017

1 reference

29 June 2017

44

1 reference

29 June 2017

1

1 reference

29 June 2017

7-9

1 reference

Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion

29 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Aerosol deposition considerations in inhalation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Therapeutic aerosols 1--physical and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Evaluation of jet nebulisers for use with gentamicin solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

Effect of lung function and mode of inhalation on penetration of aerosol into the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1992.TB14353.X

10.1111/J.2042-7158.1992.TB14353.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference